Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Toxicology cases Dr James Dear Edinburgh University Consultant posts coming up in Edinburgh! 1or even 2 in Clinical Pharmacology 1 in Toxicology Edinburgh Clinical Toxicology Research Sri Lanka Clinical and public health intervention studies on pesticide & plant self-poisoning ME Clinical trials of NAC for PCM poisoning DNB, JD £4.5M Antidote development (human, pig, fish) thiamine, cyanide, NAC ME RESEAR CH 3 PIs, 12 staff & students Biomarker studies - exosomes, microRNAs (human, pig, fish) JD MINIPIG ICU Translational studies ME Case 1. 59 M Hospital in North of England Patient presented at 11 am in morning. Came to HDU at 3 pm. Claims to have taken an overdose but will not disclose what taken other than co-codamol. Estimated 50+ tablets. Paracetamol 49 mg/L at an unknown time. Salicylate undetectable. Other meds include statin, adcal, amlodipine, thiamine, salbutamol, alendronic acid, frusemide, omeprazole. BP low but responding to fluid, systolic 105. Liver Function Tests AST 60, raised but lower than normal (normally ast and alt in 90s) Urea, Electrolytes + Creatinine Creat 186 on admission, now 124 with fluids (normally 64) Arterial Blood Gases (ABG's) H+ 90, pH 7.01, bicarb 5, serum lactate 25. Question : What is the cause of acidosis? Case 1. 59 M Hospital in North of England •Denies taking methanol or ethylene glycol but smiled when he denied it and has access to toxic alcohols through work. •Measured osmolality 370, calculated 310 •Ethanol 207 •OSMOLAL GAP = [MEASURED OSMOLALITY- CALCULATED OSMOLALITY] Calculated osmolality = (2x[sodium]) + [potassium] + [urea] + [glucose] (All should be measured in mmol/L) The normal osmolal gap is about 10 mOsm/kg H20 A significant osmolal gap is > 10-15 mOsm/kg H20 Case 1. 59 M Hospital in North of England Indications for treatment with fomepizole (or ethanol) • high anion gap metabolic acidosis OR • osmolal gap greater than 10 mosmols/kg without there being another likely cause (e.g. ethanol intoxication) Case 1. 59 M Hospital in North of England Indications for haemodialysis are any one of the following: Ethylene glycol concentration greater than 500 mg/L (0.5 g/L; 8 mmol/L) Severe metabolic acidosis Renal failure Deteriorating condition despite supportive measures Severe electrolyte imbalance A desire to shorten the duration of the poisoning Dialysis should be continued until: Plasma ethylene glycol concentration is undetectable AND Acidosis and signs of systemic toxicity have resolved Case 2. Vietnamese Male Age unknown. Hospital in midlands. Patient was involved in a house fire in a house containing cannabis plants. He was GCS 3/15 at the scene but at the time of the call was GCS 15/15. He is currently receiving airway resuscitation due to inhalation injury and has been intubated for this. Arterial blood gas sample- pH 7.28, pCO2 5.2, CO = 30%, lactate 12, base excess = -7.5. Initial carboxyhaemoglobin was 38% but now 30% and has been receiving 100% oxygen for the last hour. Question – is this cyanide toxicity? Case 2. Vietnamese Male Age unknown. Hospital in midlands. • Cyanide has a high affinity for mitochondrial cytochrome oxidase and inhibition leads to anaerobic metabolism and lactic acidosis. • The degree of lactic acidosis correlates with the severity of poisoning • The cytochrome oxidase-cyanide complex dissociates through an enzymatic reaction that transfers sulphur (from endogenous thiosulphate) to cyanide with the formation of thiocyanate, which is subsequently excreted by the kidneys. • Other endogenous methods of cyanide detoxification include binding to methaemoglobin, reaction with cysteine and incorporation into choline and methionine. Case 2. Vietnamese Male Age unknown. Hospital in midlands. In the absence of a cyanide concentration the following features suggest cyanide poisoning: Lactate > 7 mmol/L Elevated anion gap acidosis Reduced arterio-venous oxygen gradient • MILD POISONING Features: nausea, dizziness, drowsiness, hyperventilation, anxiety. Lactate concentration < 10mmol/L.Cyanide concentration < 1 mg/L (38 micromol/L) • MODERATE POISONING Features: reduced conscious level, vomiting, convulsions, hypotension. Lactate concentration 10 – 15 mmol/L Cyanide concentration 1-3 mg/L (38-114 micromol/L). • SEVERE POISONING Features: coma, fixed dilated pupils, cardiovascular collapse, respiratory failure, cyanosis. Lactate concentration >15mmol/L Cyanide concentration > 3 mg/L (114 micromol/L). Case 2. Vietnamese Male Age unknown. Hospital in midlands. • MILD POISONING • Give 25 mL of 50% sodium thiosulphate (12.5 g) intravenously • MODERATE POISONING • Give 20 mL of 1.5% dicobalt edetate solution (300 mg) IV over 1 minute followed immediately by 50 mL of 50% dextrose in adults. • OR • If dicobalt edetate is not available, give 25 mL of 50% sodium thiosulphate (12.5 g) intravenously over 10 minutes for an adult. • SEVERE POISONING – • In an adult give 20 mL of 1.5% dicobalt edetate solution (300 mg) IV over 1 minute followed immediately by 50 mL of 50% dextrose. • OR • If dicobalt edetate is not available, give 10 mL of 3% sodium nitrite solution (300 mg) IV over 5-20 minutes. The dose in children is 0.12-0.33 mL/kg or 4-10 mg/kg (maximum 10 mL or 300 mg). AND 25 mL of 50% sodium thiosulphate (12.5 g) IV over 10 minutes. The paediatric dose of sodium thiosulphate is 400 mg/kg (0.8 mL/kg of 50% solution) intravenously (Note that the paediatric dose is higher than the equivalent adult dose). • • Case 2. Vietnamese Male Age unknown. Hospital in midlands. Dr James Dear spoke to caller directly. He later called me back and confirmed that he was GCS 4/15 at the scene and was brought into department GCS 15/15.He said that the patient's condition was unlikely to be due to cyanide toxicity and more related to carbon monoxide poisoning-which was also confirmed by Professor Nick Bateman with whom Dr Dear spoke with. Dr Dear said the raised lactate was due to the hypoxia. He also confirmed the patient was stable with respect to the patient's cardiovascular status. Advised symptomatic and supportive care from this point onwards. Case 3. Male Age unknown. Hospital in North-West of England Patient has taken 1 month worth of all his medications Presented at 4am - and was thought to be asymptomatic at the time since then his BP has dropped markedly and his lactate has increased to 9.6 Agent 1 Metformin 20.50 Grams Agent 2 Carbamazepine 16.80 Grams Agent 3 Diltiazem 5.60 Grams Agent 4 Felodipine 70.00 Milligrams Agent 5 Tamsulosin 11.20 Milligrams Agent 6 Doxazosin 36.00 Milligrams Agent 7 Mirtazapine 840.00 Milligrams Agent 8 Lansoprazole 420.00 Milligrams Agent 9 Perindopril 224.00 Milligrams Agent 10 Atorvastatin 560.00 Milligrams Agent 11 Aspirin 2.10 Grams Question: Which of these are bad and how are they managed? Case 3. Male Age unknown. Hospital in North-West of England Advised to give IV calcium and transfer to HDU/ITU where they can begin on high dose insulin dextrose. They can be given vasopressors as needed and IV bicarb for acidosis as well as MDAC for the carbamazepine. If acidosis and hypotension were to continue could try haemodialysis. Have intralipid ready in case need to use it and also can give metraminol if required. What is the evidence HDI works? • Human data – around 70 people Case reports and case series Does HDI work in humans – calcium channel blocker Why does HDI work? • Is it just an inotrope or is there something special about calcium channel blockers? How does HDI work – metabolic view Blockade of L-type calcium channels impairs insulin release by the pancreatic β-islet cells and impairs glucose uptake by tissues by altering sensitivity to insulin Serum glucose concentrations correlate directly with the severity of CCB poisoning. Levine et al. 2007. Under stress the myocardium utilizes glucose as main energy store Calcium channel blockers produce a state of energy starvation Metabolic effects of HDI • Insulin increases glucose and lactate uptake by myocardial cells and improves function • Induces pyruvate dehydrogenase which increases myocardial lactate oxidation and breaks down glycolytic byproducts that impair calcium handling Does HDI work in humans – beta blocker Is there clinical evidence that HDI work in non CCB/BB poisonings? Case 4 A 27 year old man is found unconscious surrounded by packets of amitriptyline and venlafaxine (slow release). On arrival in ED his pulse is 110 bpm, BP 109/67mmHg, GCS 12/15. An ECG is performed: What does this ECG demonstrate? A) Atrial fibrillation B) Broad-complex tachycardia C) Narrow complex tachycardia D) Normal sinus rhythm What does this ECG demonstrate? A) Atrial fibrillation B) Broad-complex tachycardia C) Narrow complex tachycardia D) Normal sinus rhythm Given the clinical history of amitriptyline and venlafaxine overdose, what is the pathophysiological basis of this abnormal cardiac rhythm? A) Beta blockade B) Calcium channel blockade C) Potassium channel blockade D) Sodium channel blockade Given the clinical history of amitriptyline and venlafaxine overdose, what is the pathophysiological basis of this abnormal cardiac rhythm? A) Beta blockade B) Calcium channel blockade C) Potassium channel blockade D) Sodium channel blockade – leading to prolongation of the cardiac action potential with resultant QRS widening and potential for ventricular arrhythmias Given the ECG findings what is the first line of management? A) Amiodarone B) Calcium C) Magnesium D) Sodium bicarbonate Given the ECG findings what is the first line of management? A) Amiodarone B) Calcium C) Magnesium D) Sodium bicarbonate From Toxbase Even in the absence of an acidosis, consider alkalinisation with IV sodium bicarbonate in patients with: QRS duration greater than 120msec Arrhytmias Hypotension resistant to fluid resuscitation The patient is started on intravenous sodium bicarbonate and the ECG QRS duration is reduced. Then the patient has a 3 seizures despite treatment with a benzodiazepine. What anti-epileptic drug should be used to terminate these drug-induced seizures? • • • • A) Carbemazepine B) Phenobarbital C) Phenytoin D) Sodium valproate The patient is started on intravenous sodium bicarbonate and the ECG QRS duration is reduced. Then the patient has a 3 seizures despite treatment with a benzodiazepine. What anti-epileptic drug should be used to terminate these drug-induced seizures? • • • • A) Carbemazepine B) Phenobarbital C) Phenytoin – CONTRAINDICATED D) Sodium valproate A few hours later the patient’s seizures have settled and a repeat ECG is performed: • What does this ECG demonstrate? At risk Low risk If the nomogram indicates a risk of torsade de pointes, particularly in the presence of other risk factors (e.g. frequent ectopics, underlying structural heart disease), consider administration of magnesium sulphate IV over 10-15 minutes: adults 2 g (8 mmol Mg2+), children 25-50mg/kg (max 2g) (repeated once if necessary). Torsade de pointes and VT/VF preceded by prolonged QT should be treated with magnesium sulphate 8 mmol (2 g, or 4 mL of 2 mmol/mL solution) in adults and 25-50mg/kg (max 2g) in children intravenously over 30-120 seconds, repeated twice at intervals of 5-15 minutes if necessary. Torsade de pointes may respond to increasing the underlying heart rate through atrial or ventricular pacing or by isoprenaline (isoproterenol) infusion to achieve a heart rate of 90-110 beats/minute. Drugs that prolong the QT interval (e.g. amiodarone, quinidine) should be avoided in the presence of QT prolongation and after torsade de pointes. The patient’s condition has deteriorated significantly with his blood pressure being barely recordable and his cardiac monitor demonstrating runs of VT. His ECG now: The patient’s condition has deteriorated significantly with his blood pressure being barely recordable and his cardiac monitor demonstrating runs of VT. What treatment should be considered? A) Calcium B) Haemodialysis C) Insulin/Dextrose D) Intralipid The patient’s condition has deteriorated significantly with his blood pressure being barely recordable and his cardiac monitor demonstrating runs of VT. What treatment should be considered? A) Calcium B) Haemodialysis C) Insulin/Dextrose D) Intralipid Intralipid Do you believe Intralipid works? A) Yes B) No C) Depends D) Don’t know Do you believe Intralipid works? A) Yes B) No C) Depends – if you said depends – on what? D) Don’t know – I don’t know! Intralipid Intralipid – fact or fiction 1. Most patients with TCA poisoning who reach hospital survive In single centre study only 1 out of 302 patients died despite significant toxicity Intralipid – fact or fiction 2. Lipid sink theory – creating a pool of lipid for drug 500ml intralipid contains 100g fat Average human body contains 10,000g Is it likely that sink theory can make big difference? Intralipid – fact or fiction 3. Could intralipid increase drug absorbtion? ORAL DOSING Is it too late now for intralipid? 45 Directors of US poisons centers - all felt intralipid had a role in poisoning in setting of cardiac arrest: intralipid administered ‘always’ or ‘often’ bupivacaine (43 out of 45), verapamil (36 out of 45), amitriptyline (31 out of 45). in setting of shock; intralipid administered ‘always’ or ‘often’ bupivacaine (40 out of 45), verapamil (28 out of 45), amitriptyline (25 out of 45) Key messages QRS complex broadening reflects sodium channel blockade Treatment should be with sodium bicarbonate QT interval prolongation reflects potassium channel activity Treatment is with magnesium Seizures in the context of sodium channel blocking drugs should not be treated with phenytoin Intralipid is an option for severe cardiotoxicity but the jury is out regarding efficacy Case 5 – Male unknown age. Boxing Day. Hospital in North-west England. Presented to A&E 4am. Went into cardiac arrest at a nightclub approx 3.45am, resuscitated by paramedics on scene. Two further cardiac arrests in A&E, given adrenaline, spontaneous circulation since Temp 40. GCS 9 Agitated +++ BP 105/60, HR 77. Arterial Blood Gases (ABG's) pH 7.127, pCO2 5.06, pO2 13, Bi 12.1, BE -15 Urea, Electrolytes + Creatinine U 9.2, Cr 219, K 8.5, Na 131 CK 38000 What is the likely poison/syndrome? 3,4-methylenedioxymethamfetamine (MDMA - ecstasy) MDMA causes release of serotonin, and to a lesser extent dopamine, in the brain. Central and peripheral catecholamine release also occurs. Severe toxicity include cardiac arrhythmias, hyponatraemia., convulsions, delirium, coma, hypotension and cardiovascular collapse. MAY LEAD TO SEROTONIN SYNDROME SEROTONIN SYNDROME SEROTONIN SYNDROME SEROTONIN SYNDROME MANAGEMENT Stop the causal drugs Cooling Benzodiazepines Specific 5HT2 receptor antagonists Milder cases: Cyproheptadine cases: Chlorpromazine Severe Case 6 19 year old female Attends A&E having taken 25g of paracetamol and 1g of amitriptyline 30 minutes previously. Toxbase recommends immediate charcoal therapy for this life threatening overdose. The women has been brought to A&E by a friend. The patient has no history of deliberate self-harm, is not intoxicated and is fully alert. She states her friend convinced her to come and she still wishes to die. The patient refuses any investigations or treatment despite repeated requests from staff and her friend. No other family members are available How would you manage this patient? Options 1. A psychiatrist deems the woman to be mentally competent and fully aware of her situation, but you would forcibly detain her under common law 2. You would first assess the patient’s capacity for consent/refusal of treatment before applying common law 3. You would investigate the patient against her will, but in her best interests, by measuring her paracetamol levels at 4 hours 4. Your would, against her will, but in her best interests, treat her by, sedation, passing an NG tube and giving charcoal A competent adult can refuse treatment even when doing so may result in permanent physical injury or death All people aged 16 and over are presumed, in law, to have capacity to consent to treatment unless there is evidence to the contrary A patient with a mental illness does not, necessarily, lack competence to consent to treatment The fact that a decision is irrational or unjustified should not be taken as evidence that the individual lacks capacity To demonstrate capacity individuals should: Understand in simple language what the treatment is, its purpose and nature and why it is being proposed Understand its principal benefits, risks and alternatives Understand what the consequences of not receiving treatment are Believe the information Retain the information for long enough to use it and weigh it in the balance in order to arrive at a decision Communicate the decision Patient presents to A&E refusing treatment Doctor must assess capacity and record assessment understands, believes and is able to weigh up Psychiatrist must assess patient if mental illness is possible as may be affecting capacity Competent - cannot treat Explain that can change decision, Try to persuade Use family Not competent Essential treatment only Capacity may change Case 7 44 year old male Found collapsed at home by his wife. He is brought to A&E drowsy, smelling of alcohol having been found surrounded by empty packets of diazepam and paracetamol When his wife found him there was a note that she confirms is from the patient: Date : Today Please do not treat me at all Signed : patient His wife has now gone and you cannot contact her How would you manage this patient? Case 8 67 year old male Found collapsed at home by his wife. He is brought to A&E GCS 5 with a compromised airway having been found surrounded by empty packets of diazepam. The patient has a long history of crippling rheumatoid arthritis. The patient’s wife gives you an advance directive completed five years ago. The patient had seen family die in ITU and did not want that for himself. The advance directive stated that if the patient were to deteriorate he did not want life-sustaining treatment. The advanced directive was agreed and signed by the patient’s GP. His wife does not want to make the decision. How would you manage this patient? What makes an advanced directive valid? SCOTLAND DIFFERENT TO ENGLAND AND WALES In England and Wales the Mental Capacity Act enshrined in law the right of an adult with capacity to make an advance directive to refuse a specific treatment at a future time when they lack capacity. In Scotland no statute law but common law supports advance directives and we need to take them into account. Key points from England and Wales 1. Patient must be a competent adult at time of completion of AD 2. If referring to life-saving treatment the AD MUST be in writing, signed and witnessed and include a specific statement that it applies to a specific treatment even if life at risk. 3. Must be valid at time. If evidence that patient has changed mind over time, for example done something against the AD, then invalid. Withdrawal of AD does not need to be in writing 4. Must be applicable to the current situation If doubt exists it is acceptable to provide life saving treatment until courts decide. In overdose setting 1. Was the patient competent at time of writing AD? Was there significant mental illness? 2. Does the AD specifically apply to overdose? Often quickly reversible if intubated and ventilated 3. Has the person changed since writing AD? Five years ago may not have been depressed, but now significant depression? Friday 6th September 2013